Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Semdexa in lumbosacral radicular pain (C.L.E.A.R.)
NCT03372161Phase 3Completed
- Sponsor
- Scilex Holding
- Start
- Dec 2017
- Primary completion
- Aug 2021
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of semdexa in lumbosacral radiculopathy, sponsored by Scilex Holding. Started Dec 2017; status: completed.
02
Drugs
semdexa
03
Conditions
lumbosacral radiculopathy
Beyond the preview
Go deeper on NCT03372161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03372161.